Showing results (211-220 of 222) with videos related to
Sort By:
Pageof 23
Translational Psychiatry|February 2, 2021
Combined effects of genotype and childhood adversity shape variability of DNA methylation across ageDarina Czamara, Elleke Tissink, Johanna Tuhkanen, et al.The Journal of Clinical Psychiatry|August 13, 2025
Comparative Effectiveness Research Trial for Antidepressant Incomplete and Nonresponders With Treatment Resistant Depression (ASCERTAIN-TRD): Effect of Aripiprazole or Repetitive Transcranial Magnetic Stimulation Augmentation Versus Switching to the Antidepressant Venlafaxine on Quality of LifeClotilde Guidetti, Stefania Chaikali, Madhukar H Trivedi, et al.Journal of Affective Disorders|July 9, 2025
Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)Clotilde Guidetti, Stefania Chaikali, Madhukar H Trivedi, et al.Brain Stimulation|July 6, 2015
Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major DepressionAndrew F Leuchter, Ian A Cook, David Feifel, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 20, 2026
The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD✰David W Goodman, Rajnish Mago, Leslie Citrome, et al.Neuropsychiatric Disease and Treatment|March 26, 2026
The Use of Vagus Nerve Stimulation (VNS) in the Management of Patients with Difficult-to-Treat Major Depressive Disorder (MDD): An Expert Consensus StatementR Hamish McAllister-Williams, Gustavo Alva, Michael Banov, et al.The British Journal of Psychiatry : the Journal of Mental Science|March 25, 2026
The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensusJoseph F Goldberg, Holly A Swartz, Roger S McIntyre, et al.Journal of Attention Disorders|May 25, 2021
Effect of Impairment on the Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder in a National Survey: Nation-Wide Prevalence and Comorbidities of ADHDEyup Sabri Ercan, Gul Unsel-Bolat, Ali Evren Tufan, et al.JAMA Network Open|February 25, 2026
Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task ForceJoseph F Goldberg, Roger S McIntyre, Holly A Swartz, et al.Molecular Psychiatry|April 5, 2012
A mega-analysis of genome-wide association studies for major depressive disorder, Stephan Ripke, Naomi R Wray, et al.Pageof 23